News
Lutein in combination with vitamin A may slow vision loss
15 April 2010
A daily supplement of lutein plus vitamin A may slow vision loss associated with retinitis pigmentosa,according toa new study.
30 April 2010
Attention-deficit and hyperactivity problems in children may be associated with low vitamin B9 (folate) levels during pregnancy, suggests a new UK study.
In the study, blood samples of 100 mothers in early pregnancy were taken to measure vitamin B9 (folate) levels (1). After a follow-up of an average of 8.75 years, the mothers reported on their children's behavior using the Strengths and Difficulties Questionnaire. The results showed that low maternal levels of folate were associated with both higher childhood hyperactivity and peer problems scores.
These findings further support the hypothesis that maternal nutrition contributes to an individual’s development, with potential consequences for their behavior later in life, the researchers commented. The long-term effects of poor maternal nutrition may even branch out to the child’s ability to interact with peers or form social bonds.
The scientists speculate that the low folate levels may impair the development of the brain in the fetus. Early pregnancy is a critical time for brain development.
A Dutch study reported earlier that the children of mothers who took folic acid supplements during pregnancy were better at internalizing and externalizing problems, compared to the children of mothers who did not take supplements.
An overwhelming body of evidence links folate deficiency in early pregnancy to increased risk of neural tube defects (NTDs) in infants.
15 April 2010
A daily supplement of lutein plus vitamin A may slow vision loss associated with retinitis pigmentosa,according toa new study.
2 April 2010
Ensuring adequate intakes of vitamin D could save the German population about €37.5 billion in health care costs, according to a new review.
14 March 2016
Professor Oleg Shadyro of the Department of Chemistry at the University of Belarus has shown that coenzyme Q10 and vitamins are able to down-regulate the cellular production of phosphatidic acid (PA) in low cellular oxygen conditions which would otherwise inhibit normal cell apoptosis. Hence supplementation with these substances could improve the efficacy of radiotherapy or chemotherapy.